Market Closed -
Nasdaq
16:30:01 2024-05-03 EDT
|
5-day change
|
1st Jan Change
|
37.46
USD
|
+1.05%
|
|
+2.02%
|
-2.19%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
642.4
|
672.2
|
3,279
|
1,348
|
1,706
|
1,809
|
-
|
-
|
Enterprise Value (EV)
1 |
642.4
|
672.2
|
3,279
|
1,258
|
1,691
|
1,731
|
1,636
|
1,809
|
P/E ratio
|
47.2
x
|
18.1
x
|
45.1
x
|
27.4
x
|
29.7
x
|
24.9
x
|
21.5
x
|
17.2
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
0.33%
|
-
|
-
|
Capitalization / Revenue
|
1.15
x
|
0.98
x
|
4.24
x
|
1.18
x
|
1.23
x
|
1.03
x
|
0.86
x
|
0.81
x
|
EV / Revenue
|
1.15
x
|
0.98
x
|
4.24
x
|
1.1
x
|
1.22
x
|
0.98
x
|
0.78
x
|
0.81
x
|
EV / EBITDA
|
8.62
x
|
5.31
x
|
18.9
x
|
8.99
x
|
11.5
x
|
9.83
x
|
7.9
x
|
7.51
x
|
EV / FCF
|
-
|
-
|
-
|
21.3
x
|
42.6
x
|
23.7
x
|
16.1
x
|
-
|
FCF Yield
|
-
|
-
|
-
|
4.7%
|
2.35%
|
4.23%
|
6.22%
|
-
|
Price to Book
|
-
|
-
|
-
|
2.49
x
|
2.92
x
|
2.61
x
|
2.38
x
|
-
|
Nbr of stocks (in thousands)
|
34,893
|
36,790
|
44,623
|
45,548
|
44,548
|
48,291
|
-
|
-
|
Reference price
2 |
18.41
|
18.27
|
73.48
|
29.59
|
38.30
|
37.46
|
37.46
|
37.46
|
Announcement Date
|
20-03-12
|
21-03-10
|
22-02-24
|
23-02-23
|
24-02-27
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
560.6
|
687.2
|
773.9
|
1,144
|
1,387
|
1,762
|
2,109
|
2,227
|
EBITDA
1 |
74.5
|
126.5
|
173.1
|
140
|
146.6
|
176.1
|
207.1
|
241
|
EBIT
1 |
34.41
|
80.5
|
98.18
|
104.3
|
84.61
|
125.9
|
153.7
|
192.1
|
Operating Margin
|
6.14%
|
11.71%
|
12.69%
|
9.11%
|
6.1%
|
7.14%
|
7.29%
|
8.63%
|
Earnings before Tax (EBT)
1 |
25.84
|
178.4
|
77.75
|
86.62
|
89.84
|
126.9
|
148.3
|
182.6
|
Net income
1 |
14.12
|
37.87
|
73.86
|
49.05
|
60.72
|
74.79
|
86.93
|
110.5
|
Net margin
|
2.52%
|
5.51%
|
9.54%
|
4.29%
|
4.38%
|
4.24%
|
4.12%
|
4.96%
|
EPS
2 |
0.3900
|
1.010
|
1.630
|
1.080
|
1.290
|
1.507
|
1.745
|
2.180
|
Free Cash Flow
1 |
-
|
-
|
-
|
59.19
|
39.7
|
73.18
|
101.8
|
-
|
FCF margin
|
-
|
-
|
-
|
5.17%
|
2.86%
|
4.15%
|
4.83%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
42.27%
|
27.08%
|
41.56%
|
49.16%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
120.67%
|
65.38%
|
97.84%
|
117.16%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
0.1247
|
-
|
-
|
Announcement Date
|
20-03-12
|
21-03-10
|
22-02-24
|
23-02-23
|
24-02-27
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
227.1
|
195.1
|
-
|
-
|
317
|
294.2
|
337.2
|
348.2
|
348.2
|
353
|
413.8
|
440.6
|
444.4
|
449.4
|
501.8
|
EBITDA
1 |
74.49
|
38.74
|
-
|
-
|
57.14
|
23.65
|
29.82
|
35.77
|
51.97
|
29.01
|
35.35
|
43.76
|
56.69
|
38.92
|
43.29
|
EBIT
1 |
53.16
|
2.248
|
-
|
-
|
50.09
|
12.58
|
22.37
|
27.03
|
39.08
|
-3.87
|
23.69
|
29.25
|
42.06
|
24.91
|
36.2
|
Operating Margin
|
23.41%
|
1.15%
|
-
|
-
|
15.8%
|
4.28%
|
6.63%
|
7.76%
|
11.23%
|
-1.1%
|
5.72%
|
6.64%
|
9.46%
|
5.54%
|
7.21%
|
Earnings before Tax (EBT)
1 |
-5.505
|
-22.43
|
-
|
-
|
41.26
|
10.46
|
19.41
|
31.49
|
38.02
|
0.924
|
23.81
|
29.95
|
45.68
|
24.52
|
33.9
|
Net income
1 |
34.28
|
13.77
|
-
|
-
|
25.99
|
-2.6
|
14.62
|
13.17
|
22.06
|
12.36
|
13.97
|
18.71
|
27.56
|
10.94
|
19.9
|
Net margin
|
15.09%
|
7.06%
|
-
|
-
|
8.2%
|
-0.88%
|
4.34%
|
3.78%
|
6.34%
|
3.5%
|
3.38%
|
4.25%
|
6.2%
|
2.43%
|
3.97%
|
EPS
2 |
0.7400
|
0.3000
|
0.3100
|
0.2500
|
0.5600
|
-0.0600
|
0.3100
|
0.2800
|
0.4700
|
0.2600
|
0.3017
|
0.3867
|
0.5460
|
0.2340
|
0.4050
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
21-11-04
|
22-02-24
|
22-05-05
|
22-08-04
|
22-11-03
|
23-02-23
|
23-05-08
|
23-08-07
|
23-11-07
|
24-02-27
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
89.6
|
15.4
|
77.7
|
173
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
59.2
|
39.7
|
73.2
|
102
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
10.5%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
-
|
11.90
|
13.10
|
14.40
|
15.70
|
-
|
Cash Flow per Share
2 |
-
|
-
|
-
|
1.800
|
1.450
|
2.070
|
-
|
-
|
Capex
1 |
-
|
-
|
-
|
22.9
|
28.5
|
27.2
|
30.4
|
33.4
|
Capex / Sales
|
-
|
-
|
-
|
2%
|
2.06%
|
1.54%
|
1.44%
|
1.5%
|
Announcement Date
|
20-03-12
|
21-03-10
|
22-02-24
|
23-02-23
|
24-02-27
|
-
|
-
|
-
|
Last Close Price
37.46
USD Average target price
53.33
USD Spread / Average Target +42.37% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.19% | 1.81B | | +13.70% | 81.4B | | -29.20% | 70.18B | | +9.72% | 29.08B | | -11.43% | 16.97B | | -0.43% | 16.96B | | -0.31% | 15.26B | | +3.42% | 12.41B | | -30.70% | 11.95B | | -6.75% | 11.93B |
Other Healthcare Facilities & Services
|